These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16996883)

  • 1. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy).
    Nistri S; Olivotto I; Betocchi S; Losi MA; Valsecchi G; Pinamonti B; Conte MR; Casazza F; Galderisi M; Maron BJ; Cecchi F
    Am J Cardiol; 2006 Oct; 98(7):960-5. PubMed ID: 16996883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
    Maron MS; Olivotto I; Betocchi S; Casey SA; Lesser JR; Losi MA; Cecchi F; Maron BJ
    N Engl J Med; 2003 Jan; 348(4):295-303. PubMed ID: 12540642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy.
    Woo A; Williams WG; Choi R; Wigle ED; Rozenblyum E; Fedwick K; Siu S; Ralph-Edwards A; Rakowski H
    Circulation; 2005 Apr; 111(16):2033-41. PubMed ID: 15824202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy.
    Olivotto I; Maron MS; Adabag AS; Casey SA; Vargiu D; Link MS; Udelson JE; Cecchi F; Maron BJ
    J Am Coll Cardiol; 2005 Aug; 46(3):480-7. PubMed ID: 16053962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms.
    Autore C; Bernabò P; Barillà CS; Bruzzi P; Spirito P
    J Am Coll Cardiol; 2005 Apr; 45(7):1076-80. PubMed ID: 15808767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction.
    Desai MY; Bhonsale A; Smedira NG; Naji P; Thamilarasan M; Lytle BW; Lever HM
    Circulation; 2013 Jul; 128(3):209-16. PubMed ID: 23770748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity.
    Yang H; Woo A; Monakier D; Jamorski M; Fedwick K; Wigle ED; Rakowski H
    J Am Soc Echocardiogr; 2005 Oct; 18(10):1074-82. PubMed ID: 16198885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy.
    Losi MA; Betocchi S; Aversa M; Lombardi R; Miranda M; D'Alessandro G; Cacace A; Tocchetti CG; Barbati G; Chiariello M
    Am J Cardiol; 2004 Oct; 94(7):895-900. PubMed ID: 15464672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.
    Ommen SR; Maron BJ; Olivotto I; Maron MS; Cecchi F; Betocchi S; Gersh BJ; Ackerman MJ; McCully RB; Dearani JA; Schaff HV; Danielson GK; Tajik AJ; Nishimura RA
    J Am Coll Cardiol; 2005 Aug; 46(3):470-6. PubMed ID: 16053960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
    Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
    JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.
    Olivotto I; Maron BJ; Tomberli B; Appelbaum E; Salton C; Haas TS; Gibson CM; Nistri S; Servettini E; Chan RH; Udelson JE; Lesser JR; Cecchi F; Manning WJ; Maron MS
    J Am Coll Cardiol; 2013 Jul; 62(5):449-57. PubMed ID: 23643593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation.
    Debonnaire P; Joyce E; Hiemstra Y; Mertens BJ; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    Circ Arrhythm Electrophysiol; 2017 Feb; 10(2):. PubMed ID: 28183843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left atrial volume index: a predictor of adverse outcome in patients with hypertrophic cardiomyopathy.
    Yang WI; Shim CY; Kim YJ; Kim SA; Rhee SJ; Choi EY; Choi D; Jang Y; Chung N; Cho SY; Ha JW
    J Am Soc Echocardiogr; 2009 Dec; 22(12):1338-43. PubMed ID: 19879733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy.
    Hinojar R; Zamorano JL; Fernández-Méndez M; Esteban A; Plaza-Martin M; González-Gómez A; Carbonell A; Rincón LM; Nácher JJJ; Fernández-Golfín C
    Int J Cardiovasc Imaging; 2019 Jun; 35(6):1055-1065. PubMed ID: 30706353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of clinical presentation in symptomatic patients with hypertrophic cardiomyopathy.
    Finocchiaro G; Pinamonti B; Merlo M; Brun F; Barbati G; Sinagra G
    J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):810-8. PubMed ID: 22885530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting long-term mortality in patients with hypertrophic cardiomyopathy.
    Bostan C; Sinan UY; Canbolat P; Abaci O; Munipoglu SK; Kucukoglu S
    Echocardiography; 2014 Oct; 31(9):1056-61. PubMed ID: 24506463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical course of hypertrophic cardiomyopathy in a non selected population. The Experience of the Italian Multicenter Cardiomyopathy Study].
    Cecchi F; Olivotto I; Lazzeroni E; Chiriatti G; Sachero A; Beretta L; Giagnoni E; Renosto G; Montereggi A; Baldassarre S; Castelli G; Ciaccheri M
    G Ital Cardiol; 1997 Nov; 27(11):1133-43. PubMed ID: 9463057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of left atrial volume in patients < 20 years of age with hypertrophic cardiomyopathy.
    Menon SC; Ackerman MJ; Cetta F; O'Leary PW; Eidem BW
    Am J Cardiol; 2008 Nov; 102(10):1390-3. PubMed ID: 18993161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-positive status in patients with hypertrophic cardiomyopathy is associated with higher rates of heart failure events.
    Li Q; Gruner C; Chan RH; Care M; Siminovitch K; Williams L; Woo A; Rakowski H
    Circ Cardiovasc Genet; 2014 Aug; 7(4):416-22. PubMed ID: 24909666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of Genetic Testing for the Prediction of Long-Term Outcome in Patients With Hypertrophic Cardiomyopathy.
    van Velzen HG; Vriesendorp PA; Oldenburg RA; van Slegtenhorst MA; van der Velden J; Schinkel AFL; Michels M
    Am J Cardiol; 2016 Sep; 118(6):881-887. PubMed ID: 27476098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.